OPHDIAT©: Quality-assurance programme plan and performance of the network

被引:19
作者
Erginay, A. [1 ]
Chabouis, A. [2 ]
Viens-Bitker, C. [2 ]
Robert, N. [1 ]
Lecleire-Collet, A. [1 ]
Massin, P. [1 ]
机构
[1] Hop Lariboisiere, AP HP, Dept Ophthalmol, F-75475 Paris 10, France
[2] Direct Gen, F-75004 Paris, France
关键词
Quality assurances; Diabetic retinopathy; Telemedicine; OPHDIAT (c); Screennig;
D O I
10.1016/j.diabet.2008.01.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims. - There is a need for evaluation of screening and grading services for diabetic retinopathy (DR) in compliance with quality-assurance (QA) standards. We describe the screening/gradingg QA programme set up for OPHDIAT (c) over the 2005-2006 period. Methods, - Screening and grading objectives, evaluation criteria and minimum acceptable QA standards were set. To ensure the quality of DR photos, the proportion of nongradable photos in at least one eye had to be less than 10%. To ensure grading accuracy, intergrading agrement had to be greater than 90%. Grader-generated reports had to be available in less than 48 h for more than 80% photos. Readers had to oracle 500 to 3000 photos per year. Results. - Sixteen screening centres were opened between June 2004 and December 2006. and 14,769 patients were screened. Percentages of nongradable photos were consistently below the QA requirement (less than 10%). overall, 800 photos were graded a second time by a reader blinded to original grading: agreement between graders ranged from 92 to 99%. More than 90% of grader-generated reports were produced within 48 h. The number of readings by each grader nearly achieved the QA standard. Conclusion. - QA for DR telescreening should be a Continuous process to provide performance feedback, thus guaranteeing a high standard for delivered results. Almost all of the predetermined QA standards in OPHDIAT (c) for screening and grading were met. Besides the quality/sensitivity of the screening/grading, modalities, it is important to evaluate at-risk patients so that they can be treated efficiently: this should be addressed in a global QA programme. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:235 / 242
页数:8
相关论文
共 20 条
[1]  
ABRAMOFF MD, 2007, DIABETES CARE 1116
[2]  
[Anonymous], 1991, OPHTHALMOLOGY S, V98, pS766
[3]   Diabetic retinopathy [J].
Frank, RN .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01) :48-58
[4]   A pilot quality assurance scheme for diabetic retinopathy risk reduction programmes [J].
Garvican, L ;
Scanlon, PH .
DIABETIC MEDICINE, 2004, 21 (10) :1066-1074
[5]   Effectiveness of screening and monitoring tests for diabetic retinopathy - a systematic review [J].
Hutchinson, A ;
McIntosh, A ;
Peters, J ;
O'Keeffe, C ;
Khunti, K ;
Baker, R ;
Booth, A .
DIABETIC MEDICINE, 2000, 17 (07) :495-506
[6]   A new grading system from color fundus photographs for screening for diabetic retinnopathy [J].
Lecleire-Collet, A. ;
Erginay, A. ;
Angioi-Duprez, K. ;
Deb-Joardar, N. ;
Gain, P. ;
Massin, P. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2007, 30 (07) :674-687
[7]   Quality assurance for diabetic retinal screening-can we afford it? [J].
Leese, G. P. ;
Ellis, J. D. .
DIABETIC MEDICINE, 2007, 24 (06) :579-581
[8]  
Massin P, 1996, DIABETES METAB, V22, P203
[9]   Evaluation of a screening program for diabetic retinopathy in a primary care setting [J].
Massin, P ;
Aubert, JP ;
Eschwege, E ;
Erginay, A ;
Bourovitch, JC ;
BenMehidi, A ;
Nougarède, M ;
Bouée, S ;
Fagnani, F ;
Tcherny, MS ;
Jamet, M ;
Bouhassira, M ;
Marre, M .
DIABETES & METABOLISM, 2005, 31 (02) :153-162
[10]  
MASSIN P, DIABETES ME IN PRESS, V34